Contact
Please use this form to send email to PR contact of this press release:
Lightlake Therapeutics Inc. Announces Name Change to Opiant Pharmaceuticals, Inc.
TO:
Please use this form to send email to PR contact of this press release:
Lightlake Therapeutics Inc. Announces Name Change to Opiant Pharmaceuticals, Inc.
TO: